Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ALBATROSS NEUROFEEDBACK KLINIKK AS
AS
Active
Org 928634345
Leitevegen 58, 5550 Sveio
Andre helsetjenester · NACE 86909
Est. 2022
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 58K
-71% vs 2023
EBITDA margin
-4.5%
-103% vs 2023
Equity ratio
-132.6%
Financial strength
Net profit 2024
NOK -33K
-150% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 58K
-71%
EBITDA
NOK -3K
-103%
Net profit
NOK -33K
-150%
Total assets
NOK 14K
-80%
Equity
NOK -18K
-227%
Employees
2
—
Company information
Legal name
ALBATROSS NEUROFEEDBACK KLINIKK AS
Org number
928634345
Legal form
Aksjeselskap
NACE code
86909 · Andre helsetjenester
Founded
28. januar 2022
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder og nestleder i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Neurofeedbacktrening.
Contact
Address
Leitevegen 58, 5550 Sveio
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Andre helsetjenester
Companies in Sveio
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
87
199
58
Staff expenses
−9
−37
−4
EBITDA
−45
94
−3
Depreciation & amort.
−26
−28
−28
EBIT
−71
66
−31
Net financials
−5
−1
0
Profit before tax
−75
65
−31
Tax
−0
−0
2
Net profit
−75
65
−33
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
100
67
14
Equity
−51
14
−18
Long-term debt
94
0
0
Short-term debt
57
53
32
Total debt
151
53
32
Financial ratios
5-year trend
EBITDA margin
-4.5%
This company
15.8%
Market median
-128% vs market
2022
2024
Equity ratio
-132.6%
This company
38.2%
Market median
-447% vs market
2022
2024
Return on equity
-3268700.0%
This company
18.4%
Market median
-17764774% vs market
2022
2024
Net profit margin
-56.4%
This company
8.1%
Market median
-796% vs market
2022
2024
Asset turnover
4.20×
This company
1.12×
Market median
+275% vs market
2022
2024
Debt / equity
1.75×
This company
0.62×
Market median
-182% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
WS
Willy Sørensen
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
ML
Morten Langeland
Deputy Chairman
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ALBATROSS NEUROFEEDBACK KLINIKK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Willy Sørensen
Chief Executive Officer
0 companies
Morten Langeland
Deputy Chairman
0 companies